Trokendi xr and Abilify drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Trokendi xr (topiramate) and Abilify (aripiprazole). Common drug interactions include vomiting among females and ageusia among males.

The phase IV clinical study analyzes what interactions people have when they take Trokendi xr and Abilify. It is created by eHealthMe based on reports of 19 people who take the same drugs from the FDA, and is updated regularly.

What is Trokendi xr?

Trokendi xr has active ingredients of topiramate. It is often used in migraine. eHealthMe is studying from 1,790 Trokendi xr users. Check the latest studies of Trokendi xr.

What is Abilify?

Abilify has active ingredients of aripiprazole. It is often used in depression. eHealthMe is studying from 101,454 Abilify users. Check the latest studies of Abilify.



On Jul, 08, 2026

19 people who take Trokendi xr and Abilify together, and have interactions are studied.

Trokendi xr and Abilify drug interactions.

What are the common drug interactions of Trokendi Xr and Abilify, by gender? *:

female:

  1. Vomiting
  2. Abnormal behaviour
  3. Abnormal dreams
  4. Anxiety
  5. Cold sweat
  6. Decreased appetite
  7. Dehydration (dryness resulting from the removal of water)
  8. Drug withdrawal headache
  9. Duodenogastric reflux (bile flows upward from the small intestine into the stomach)
  10. Electrocardiogram t wave inversion

male:

  1. Ageusia (loss of taste functions of the tongue)
  2. Aphasia (damage to the parts of the brain that control language)
  3. Anxiety
  4. Back disorder
  5. Balance disorder
  6. Dizziness
  7. Drug level decreased
  8. Eructation (release of gas from the digestive tract)
  9. Fibromyalgia (a long-term condition which causes pain all over the body)
  10. Mood altered (changes in mood)

What are the common drug interactions of Trokendi Xr and Abilify, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

  1. Fall
  2. Keratosis pilaris (a condition in which there are numerous rough follicular spots, which may be skin coloured, red or brown)
  3. Seborrhoeic dermatitis (a common, inflammatory skin condition that causes flaky, white to yellowish scales to form on oily areas such as the scalp)
  4. Enuresis (repeated inability to control urination)

10-19:

n/a

20-29:

  1. Abnormal behaviour
  2. Drug level decreased

30-39:

  1. Cluster headache (one-sided head pain with tearing)
  2. Headache (pain in head)
  3. Nausea (feeling of having an urge to vomit)
  4. Self-injurious ideation
  5. Vomiting

40-49:

  1. Altered state of consciousness (altered state of mind)
  2. Chest pain
  3. Dyspnoea (difficult or laboured respiration)
  4. Fatigue (feeling of tiredness)
  5. Somnolence (a state of near-sleep, a strong desire for sleep)
  6. Tachycardia (a heart rate that exceeds the range of 100 beats/min)

50-59:

  1. Abnormal dreams
  2. Ageusia (loss of taste functions of the tongue)
  3. Anxiety
  4. Aphasia (damage to the parts of the brain that control language)
  5. Cold sweat
  6. Decreased appetite
  7. Dehydration (dryness resulting from the removal of water)
  8. Drug withdrawal headache
  9. Duodenogastric reflux (bile flows upward from the small intestine into the stomach)
  10. Electrocardiogram t wave inversion

60+:

  1. Anaemia (lack of blood)
  2. Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
  3. Change of bowel habit
  4. Constipation
  5. Diarrhoea
  6. Fall
  7. Hemiparesis (weakness on one side of the body)
  8. Joint dislocation (a joint position is changed from normal position)
  9. Limb injury

What are the existing conditions these people have? *

  1. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 10 people, 52.63%
  2. Tic (a sudden, repetitive, nonrhythmic motor movement or vocalization involving discrete muscle groups): 1 person, 5.26%
  3. Sinusitis (inflammation of sinus): 1 person, 5.26%
  4. Seizures (abnormal excessive or synchronous neuronal activity in the brain): 1 person, 5.26%
  5. Pain: 1 person, 5.26%
  6. Neuropathy Peripheral (surface nerve damage): 1 person, 5.26%
  7. Muscle Spasticity (tight or stiff muscles and an inability to control those muscles): 1 person, 5.26%
  8. Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 1 person, 5.26%
  9. Intervertebral Disc Protrusion (spinal disc protrusion): 1 person, 5.26%
  10. Hypopituitarism (diminished hormone secretion by the pituitary gland, causing dwarfism in children and premature aging in adults): 1 person, 5.26%

* Approximation only. Some reports may have incomplete information.

Do you take Trokendi xr and Abilify?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Trokendi xr and Abilify:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Trokendi xr:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Abilify:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Trokendi xr and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Abilify and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on topiramate and aripiprazole (the active ingredients of Trokendi xr and Abilify, respectively), and Trokendi xr and Abilify (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: